Vascular Wrap trial results demonstrate reduced incidence of amputation.

(From Chemical Business NewsBase - Press Release)

Angiotech Pharmaceuticals Inc announced results from its European first-in-man study for its Vascular Wrap paclitaxel-eluting product. The trial produced evidence that the Vascular Wrap reduced the overall incidence of leg amputation and prolonged limb retention time for patients in the treatment arm relative to the control group. In fact, for the patients that underwent an amputation during the study period, the mean interval to amputation for patients treated with the Vascular Wrap was 156 days - more than double the mean interval to amputation for the control, which was 76 days. At the same time, the Vascular Wrap …